Yingmei Han

Title: Innovations and Contributions of Inventor Yingmei Han

Introduction

Yingmei Han is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative peptide derivatives and their applications in medicine. With a total of 2 patents, his work has the potential to impact the treatment of various health conditions.

Latest Patents

Yingmei Han's latest patents include two groundbreaking inventions. The first patent, titled "Glucagon-derived peptide and use thereof," describes a polypeptide derivative that exhibits a dual agonistic effect on GC/GLP-1 receptors. This innovation generates a synergistic effect on energy metabolism, effectively reducing blood glucose levels while also aiding in weight loss and improving body fat levels. The efficacy of this polypeptide derivative surpasses that of a single GLP-1 receptor agonist.

The second patent, "Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof," outlines a method for preparing cycloastragenol monoglucoside (CMG). This method involves using astragaloside IV or Astragali extracts as raw materials, followed by hydrolysis and purification steps. The resulting cycloastragenol-6-O-β-D-glucoside is proposed for use in the preparation of medicaments aimed at treating cardiovascular diseases.

Career Highlights

Yingmei Han has worked with esteemed organizations such as the Tianjin Institute of Pharmaceutical Research Co., Ltd. and the Tianjin Institute of Pharmaceutical Research. His experience in these institutions has allowed him to refine his research skills and contribute to significant advancements in pharmaceutical sciences.

Collaborations

Yingmei has collaborated with notable colleagues, including Naxia Zhao and Guangping Xia. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful research outcomes.

Conclusion

Yingmei Han's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work not only addresses critical health issues but also showcases the potential of peptide derivatives in therapeutic applications.